| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 1998 Oxford University Press
other |
Developmental Exposure to Lead Causes Persistent Immunotoxicity in Fischer 344 Rats
Department of Microbiology and Immunology, College of Veterinary Medicine, and Institute for Comparative and Environmental Toxicology, Cornell University Ithaca, New York 14853-6401
Received August 8, 1997; accepted January 9, 1998
Lead has been shown to exert toxic effects during early development. In these in vivo and ex vivo experiments, the effect of lead on the immune system of the developing embryo was assessed. Nine-week-old female Fischer 344 rats were exposed to lead acetate (0,100,250, and 500 ppm lead) in their drinking water during breeding and pregnancy (exposure was discontinued at parturition). Offspring received no additional lead treatment after birth. Immune function was assessed in female offspring at 13 weeks of age. Dams in lead-exposed groups were not different from controls with respect to the immune endpoints used in these experiments; however, in the offspring, lead modulated important immune parameters at modest exposure levels. Macrophage cytokine and effector function properties (tumor necrosis factor-
and nitric oxide production) were elevated in the 250 ppm group, while cell-mediated immune function was depressed, as shown by a decrease in delayed-type hypersensitivity reactions in the 250 ppm group. Interferon-
levels were decreased in the 500 ppm treatment group. Serum levels of IgE were increased in rats exposed to 100 ppm lead. These results indicate that exposure of mothers to moderate levels of lead produces chronic immune modulation in their F344 rat offspring exposed in utero. Since the mothers were not susceptible to chronic immune alterations, a developmental bias to the immunotoxic effects of lead is indicated. The differences observed are consistent with the possibility that lead may bias T helper subset development and/or function, resulting in alterations in the balance among type 1 and type 2 immune responses.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  R. R Dietert and M. S Piepenbrink The managed immune system: protecting the womb to delay the tomb Human and Experimental Toxicology, February 1, 2008; 27(2): 129 - 134. [Abstract] [PDF]
|
|
|
|
|
|
M. Valentino, V. Rapisarda, L. Santarelli, M. Bracci, M. Scorcelletti, L. Di Lorenzo, F. Cassano, and L. Soleo Effect of lead on the levels of some immunoregulatory cytokines in occupationally exposed workers Human and Experimental Toxicology, July 1, 2007; 26(7): 551 - 556. [Abstract] [PDF]
|
|
|
|
 |
|
 Y. Heo, T. K. Mondal, D. Gao, J. Kasten-Jolly, H. Kishikawa, and D. A. Lawrence Posttranscriptional Inhibition of Interferon-Gamma Production by Lead Toxicol. Sci., March 1, 2007; 96(1): 92 - 100. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Gao, J. Kasten-Jolly, and D. A. Lawrence The Paradoxical Effects of Lead in Interferon-Gamma Knockout BALB/c Mice Toxicol. Sci., February 1, 2006; 89(2): 444 - 453. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Y. A. Hemdan, F. Emmrich, K. Adham, G. Wichmann, I. Lehmann, A. El-Massry, H. Ghoneim, J. Lehmann, and U. Sack Dose-Dependent Modulation of the In Vitro Cytokine Production of Human Immune Competent Cells by Lead Salts Toxicol. Sci., July 1, 2005; 86(1): 75 - 83. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Holsapple, L. A. Burns-Naas, K. L. Hastings, G. S. Ladics, A. L. Lavin, S. L. Makris, Y. Yang, and M. I. Luster A Proposed Testing Framework for Developmental Immunotoxicology (DIT) Toxicol. Sci., January 1, 2005; 83(1): 18 - 24. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.O. Shaheen, R.B. Newson, A.J. Henderson, P.M. Emmett, A. Sherriff, M. Cooke, and the ALSPAC Study Team Umbilical cord trace elements and minerals and risk of early childhood wheezing and eczema Eur. Respir. J., August 1, 2004; 24(2): 292 - 297. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y Heo, B-K Lee, K-D Ahn, and D A Lawrence Serum IgE elevation correlates with blood lead levels in battery manufacturing workers Human and Experimental Toxicology, May 1, 2004; 23(5): 209 - 213. [Abstract] [PDF]
|
|
|
|
|
|
R R Dietert, J-E Lee, and T L Bunn Developmental immunotoxicology: emerging issues Human and Experimental Toxicology, September 1, 2002; 21(9-10): 479 - 485. [Abstract] [PDF]
|
|
|
|
 |
|
 M o. Ayatollahi Study of the impact of blood lead level on humoral immunity in humans Toxicology and Industrial Health, February 1, 2002; 18(1): 39 - 44. [Abstract] [PDF]
|
|
|
|
|
|
T. L. Bunn, P. J. Parsons, E. Kao, and R. R. Dietert Exposure to Lead during Critical Windows of Embryonic Development: Differential Immunotoxic Outcome Based on Stage of Exposure and Gender Toxicol. Sci., November 1, 2001; 64(1): 57 - 66. [Abstract] [Full Text] [PDF]
|
|